Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
Share This

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Latest Mizuho News

The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line

The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line

June 9, 2026
Mizuho Americas wins five FCS Portfolio Awards

Mizuho Americas wins five FCS Portfolio Awards

May 20, 2026
Mizuho Head of Investment: AI is imacting every sector in the global economy

Mizuho Head of Investment: AI is imacting every sector in the global economy

June 9, 2026

Mizuho news from around the globe

back-to-top-blue